BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

27 related articles for article (PubMed ID: 30776925)

  • 1. Preliminary results of ultrasound-guided laser ablation for unresectable metastases to retroperitoneal and hepatic portal lymph nodes.
    Mou Y; Zhao Q; Zhong L; Chen F; Jiang T
    World J Surg Oncol; 2016 Jun; 14(1):165. PubMed ID: 27338093
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Safety and efficacy of percutaneous image-guided ablation for soft tissue sarcoma metastases to the liver.
    Awad A; Pal K; Yevich S; Kuban JD; Tam A; Odisio BC; Gupta S; Habibollahi P; Bishop AJ; Conley AP; Somaiah N; Araujo DM; Zarzour MA; Ratan R; Roland CL; Keung EZ; Huang SY; Sheth RA
    Cancer; 2024 Apr; ():. PubMed ID: 38642369
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Image-Guided Ablation Therapies for Extrahepatic Metastases from Hepatocellular Carcinoma: A Review.
    Umakoshi N; Matsui Y; Tomita K; Uka M; Kawabata T; Iguchi T; Hiraki T
    Cancers (Basel); 2023 Jul; 15(14):. PubMed ID: 37509326
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Efficacy and Dose-Response Relationship of Stereotactic Body Radiotherapy for Abdominal Lymph Node Metastases from Hepatocellular Carcinoma.
    Wang Y; Li Q; Zhang L; Liu S; Zhu J; Yang Y; Liu M; Zhang Y; Xi M
    Oncologist; 2023 Jun; 28(6):e369-e378. PubMed ID: 37011232
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Development and Validation of a Novel Model to Predict Regional Lymph Node Metastasis in Patients With Hepatocellular Carcinoma.
    Chen X; Lu Y; Shi X; Han G; Zhao J; Gao Y; Wang X
    Front Oncol; 2022; 12():835957. PubMed ID: 35223515
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Challenges Facing Percutaneous Ablation in the Treatment of Hepatocellular Carcinoma: Extension of Ablation Criteria.
    Zhou Y; Yang Y; Zhou B; Wang Z; Zhu R; Chen X; Ouyang J; Li Q; Zhou J
    J Hepatocell Carcinoma; 2021; 8():625-644. PubMed ID: 34189133
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Feasibility and safety of percutaneous computed tomography guided radiofrequency ablation of lymph nodes in oligometastatic patients: a single center's experience.
    Filippiadis D; Charalampopoulos G; Tsochatzis A; Reppas L; Mazioti A; Kelekis A; Kelekis N
    Br J Radiol; 2021 May; 94(1121):20200445. PubMed ID: 33756082
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Laparoscopic radiofrequency ablation of solitary small hepatocellular carcinoma in the caudate lobe.
    Jiang K; Zhang W; Su M; Liu Y; Zhao X; Wang J; Yao M; Ogbonna J; Dong J; Huang Z
    Eur J Surg Oncol; 2013 Nov; 39(11):1236-42. PubMed ID: 23993049
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Percutaneous ablation of hepatocellular carcinoma: current status.
    McWilliams JP; Yamamoto S; Raman SS; Loh CT; Lee EW; Liu DM; Kee ST
    J Vasc Interv Radiol; 2010 Aug; 21(8 Suppl):S204-13. PubMed ID: 20656230
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Safety and technical feasibility of percutaneous ablation for lymph node metastases of hepatocellular carcinoma.
    Yuan Z; Xing A; Zheng J; Li W
    Int J Hyperthermia; 2019 Jan; 36(1):160-168. PubMed ID: 30776925
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Percutaneous CT-guided Radiofrequency Ablation for Lymph Node Oligometastases from Hepatocellular Carcinoma: A Propensity Score-matching Analysis.
    Pan T; Xie QK; Lv N; Li XS; Mu LW; Wu PH; Zhao M
    Radiology; 2017 Jan; 282(1):259-270. PubMed ID: 27399327
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Survival benefits of computed tomography-guided thermal ablation for adrenal metastases from hepatocellular carcinoma.
    Lyu N; Kong Y; Pan T; Mu L; Sun X; Li S; Deng H; Lai J; Zhao M
    Int J Hyperthermia; 2019; 36(1):1003-1011. PubMed ID: 31544545
    [No Abstract]   [Full Text] [Related]  

  • 13. Percutaneous radiofrequency ablation for pulmonary metastases from hepatocellular carcinoma: results of a multicenter study in Japan.
    Hiraki T; Yamakado K; Ikeda O; Matsuoka T; Kaminou T; Yamagami T; Gobara H; Mimura H; Kawanaka K; Takeda K; Yamashita Y; Inoue Y; Ogawa T; Nishimura T; Kanazawa S
    J Vasc Interv Radiol; 2011 Jun; 22(6):741-8. PubMed ID: 21531575
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Microwave ablation for the treatment of hepatocellular carcinoma that met up-to-seven criteria: feasibility, local efficacy and long-term outcomes.
    Xu Y; Shen Q; Liu P; Xu Z; Wu P; Lu Z; Chen Y; Huang B; Qian G
    Eur Radiol; 2017 Sep; 27(9):3877-3887. PubMed ID: 28188425
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Percutaneous CT-guided radiofrequency ablation for patients with extrahepatic oligometastases of hepatocellular carcinoma: long-term results.
    Mu L; Sun L; Pan T; Lyu N; Li S; Li X; Wang J; Xie Q; Deng H; Zheng L; Peng J; Shen L; Fan W; Wu P; Zhao M
    Int J Hyperthermia; 2018 Feb; 34(1):59-67. PubMed ID: 28540809
    [TBL] [Abstract][Full Text] [Related]  

  • 16.
    ; ; . PubMed ID:
    [No Abstract]   [Full Text] [Related]  

  • 17.
    ; ; . PubMed ID:
    [No Abstract]   [Full Text] [Related]  

  • 18.
    ; ; . PubMed ID:
    [No Abstract]   [Full Text] [Related]  

  • 19.
    ; ; . PubMed ID:
    [No Abstract]   [Full Text] [Related]  

  • 20.
    ; ; . PubMed ID:
    [No Abstract]   [Full Text] [Related]  

    [Next]    [New Search]
    of 2.